Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 17 Neoplasm Metastasis 8 Rectal Neoplasms 6 Colonic Neoplasms 4 Uveal Melanoma 3 Stomach Neoplasms 2 Neoplasms 2 Recurrence 1 Pancreatic Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Colorectal Cancer Metastatic 1 Carcinoid Tumor 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Advanced Colorectal Cancer 1

Interventions

Oxaliplatin 3 regorafenib 2 Irinotecan 2 Drug Therapy 2 Cetuximab 2 Capecitabine 2 trifluridine tipiracil drug combination 1 surufatinib 1 raltitrexed 1 paclitaxel poliglumex 1 nimotuzumab 1 endostar protein 1 durvalumab 1 defactinib 1 aflibercept 1 Panitumumab 1 Fluorouracil 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Colorectal Cancer × aflibercept × Clear all

NCT04252456 2020-02-05

DISTINCTIVE

Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente

Phase NA Unknown

Gastrointestinal

Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡